IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.849
NA - Nord America 5.067
AS - Asia 2.639
SA - Sud America 894
AF - Africa 65
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.995
RU - Federazione Russa 2.967
SG - Singapore 1.147
BR - Brasile 782
CN - Cina 770
IE - Irlanda 760
SE - Svezia 687
UA - Ucraina 338
DE - Germania 310
HK - Hong Kong 308
IT - Italia 190
FI - Finlandia 149
GB - Regno Unito 138
FR - Francia 134
VN - Vietnam 102
IN - India 75
PL - Polonia 70
AR - Argentina 34
BD - Bangladesh 34
CA - Canada 30
IQ - Iraq 27
MX - Messico 27
AT - Austria 24
TR - Turchia 22
PK - Pakistan 21
MA - Marocco 19
UZ - Uzbekistan 19
EC - Ecuador 17
BE - Belgio 16
VE - Venezuela 16
NL - Olanda 15
JP - Giappone 12
KE - Kenya 12
ZA - Sudafrica 12
CL - Cile 10
ID - Indonesia 10
IR - Iran 10
CO - Colombia 9
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
LT - Lituania 7
MY - Malesia 7
PE - Perù 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
ES - Italia 6
IL - Israele 6
NP - Nepal 6
PH - Filippine 6
EG - Egitto 5
JO - Giordania 5
KR - Corea 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
JM - Giamaica 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
CG - Congo 2
CH - Svizzera 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
PA - Panama 1
SR - Suriname 1
SV - El Salvador 1
Totale 14.519
Salva come PNG Salva come JPEG
Città #
Moscow 893
Dublin 760
Jacksonville 618
Ashburn 614
Singapore 605
Chandler 600
Dallas 520
Nyköping 437
Dearborn 390
Hong Kong 308
Beijing 298
San Jose 161
The Dalles 127
Princeton 120
Medford 116
Los Angeles 111
Cambridge 109
Lauterbourg 99
Ann Arbor 81
Boardman 79
Munich 79
Des Moines 72
Warsaw 67
Buffalo 62
New York 59
Messina 57
São Paulo 52
Ho Chi Minh City 46
Tianjin 37
San Mateo 34
Woodbridge 33
Guangzhou 31
Turku 31
Jinan 30
Wilmington 28
Lancaster 23
Belo Horizonte 22
Orem 22
Vienna 21
Chennai 19
Rio de Janeiro 19
Santa Clara 19
Seattle 19
Denver 18
Frankfurt am Main 18
Phoenix 17
Redondo Beach 17
Brussels 16
Haikou 15
Tashkent 15
Brasília 13
Hanoi 13
Houston 13
Nanjing 13
Stockholm 13
Atlanta 12
Salvador 12
Shanghai 12
Shenyang 12
Tokyo 12
Boston 11
Curitiba 11
Hefei 11
London 11
Montreal 11
Shenzhen 11
Taizhou 11
Baghdad 10
Chicago 10
Düsseldorf 10
Francofonte 10
Hebei 10
Johannesburg 10
Manchester 10
Mumbai 10
Taiyuan 10
Washington 10
Campinas 9
Milan 9
Nairobi 9
Pune 9
San Francisco 9
Sorocaba 9
Ardabil 8
Brooklyn 8
Fuzhou 8
Helsinki 8
Nanchang 8
Amsterdam 7
Columbus 7
Contagem 7
Dhaka 7
Mexico City 7
Ankara 6
Auburn Hills 6
Changsha 6
Charlotte 6
Council Bluffs 6
Fortaleza 6
Goiânia 6
Totale 8.517
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 244
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 199
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 185
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 184
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 181
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 181
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 181
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 174
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 174
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 170
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 170
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 169
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 169
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 167
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 166
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 163
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 162
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 162
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 160
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 157
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 157
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 156
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 156
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 155
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 155
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 155
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 151
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 150
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 149
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 147
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 147
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 145
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 145
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 144
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 143
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 142
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 139
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 139
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 137
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 136
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 136
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 135
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 135
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 133
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 131
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 131
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 130
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 125
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 125
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 124
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 123
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 123
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 123
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 122
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 121
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 120
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 118
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 118
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 117
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 116
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 116
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 116
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 115
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 114
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 114
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 113
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 112
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 108
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 108
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 108
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 107
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 105
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 104
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 104
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 103
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 103
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 102
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 102
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 102
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 102
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 102
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 102
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 101
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 101
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 101
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 100
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 100
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 99
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 99
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 99
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 97
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 97
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 95
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 93
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 92
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 92
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 90
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 90
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 89
Totale 13.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 105 83 39
2021/2022700 6 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20266.465 304 501 483 477 513 1.542 820 841 785 199 0 0
Totale 14.608